Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
89526 trials found · Page 119 of 4477
-
New targeted drug trial offers hope for rare lung cancer subtype
Disease control Not yet recruitingThis is a single-arm, phase II clinical trial evaluating the efficacy and safety of FHD-286, a SMARCA4/2 inhibitor, in participants with POU2F3-expressing small cell lung cancer who have received at least one prior line of platinum-based therapy. All participants will receive FHD…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 03, 2026 10:59 UTC
-
Can stem cells and brain gadgets stop memory decline? new trial aims to find out
Disease control Not yet recruitingThis study aims to evaluate the efficacy of community-based early detection and targeted interventions, including stem cell therapy and wearable non-invasive brain-computer interface (BCI) devices, for Mild Cognitive Impairment (MCI) in adults aged 55 years and older residing in …
Phase: EARLY_PHASE1 • Sponsor: Noah Tech, Corp. • Aim: Disease control
Last updated Apr 26, 2026 19:39 UTC
-
CPR breathing gets a High-Tech upgrade: study tests Life-Saving precision
Disease control Not yet recruitingCardiac arrest is a life-threatening emergency that requires immediate treatment with cardiopulmonary resuscitation (CPR). While chest compressions circulate blood, manual ventilation provides oxygen to the patient. Current CPR guidelines recommend specific ventilation rates and …
Phase: NA • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New hope for hard-to-treat breast cancer? drug targets hidden genetic switch
Disease control Not yet recruitingThis is an open-label, single-arm, single-center,exploratory clinical study.
Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Could 100 hours of therapy transform life after stroke?
Symptom relief Not yet recruitingResearch question Does participation in an Intensive Comprehensive Aphasia Programme produce a meaningful change in the communication of people with aphasia, their quality of life and that of their carers? Background Aphasia is a persistent language disorder that severely impair…
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated May 03, 2026 10:56 UTC
-
New vaccine aims to better protect transplant patients against COVID-19
⭐️ VACCINE ⭐️ Not yet recruitingThis phase IIb trial compares the effect of LUNAR-COV19 vaccine to Comirnaty vaccine in treating adult patients who have received a hematopoietic cell transplant (HCT). Guidelines recommend repeating severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination of 3 me…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 01, 2026 16:01 UTC
-
Colombia takes on cancer: first CAR-T trial for relapsed blood cancers
Disease control Not yet recruitingThis is a hybrid type two study, with two simultaneous development phases. Phase A involves developing a public-private partnership to create the conditions for implementing CAR-T cell therapies in Colombia. Phase B will be a single-arm, non-randomized pilot clinical trial in pat…
Phase: NA • Sponsor: GUSTAVO SALGUERO • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Lung cancer showdown: surgery vs. radiation in High-Risk patients
Disease control Not yet recruitingIn low-risk patients with stage I non-small cell lung cancer (NSCLC) surgical treatment with an anatomical resection is currently the standard of care. For medically inoperable patients with stage I NSCLC, radiation therapy is currently the standard treatment. The latest generat…
Phase: NA • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Can a common heart drug stop PTSD before it starts?
Prevention Not yet recruitingThe goal of this clinical trial is to evaluate the effect of early propranolol administration on the occurrence of post-traumatic stress disorder (PTSD) symptoms at five weeks in adult female victims of sexual violence. The investigators hypothesize that propranolol administrati…
Phase: PHASE2 • Sponsor: University Hospital, Tours • Aim: Prevention
Last updated Apr 29, 2026 15:02 UTC
-
Could your own stem cells slow a rare brain disease?
Disease control Not yet recruitingThis study investigates the safety and efficacy of autologous stem cell therapy in patients with Multiple System Atrophy (MSA), a rare and progressive neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. The trial will evaluate funct…
Phase: PHASE2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC
-
New hope for rare ovarian cancer: drug shrinks tumors in 40% of patients
Disease control Not yet recruitingOvarian clear cell carcinoma (OCCC) is a relatively rare but highly malignant epithelial ovarian cancer, accounting for 5%-10% of all ovarian cancers. The incidence of this tumor has significant racial disparity, with the highest incidence in Asians, accounting for 25% of ovarian…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
Virus cocktail vs. staph: new hope for diabetic foot wounds?
Disease control Not yet recruitingThe primary objective of this study is to compare the efficacy of standard treatment associated with a topical anti-staphylococcal bacteriophage cocktail versus standard treatment plus placebo for diabetic foot ulcers monoinfected by methicillin-resistant or susceptible S. aureus…
Phase: PHASE1, PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Engineered immune cells take on deadly childhood brain cancer
Disease control Not yet recruitingThis study is being conducted in patients with GPC3-positive brain tumors that have recurred or have not responded to standard therapy. Atypical teratoid rhabdoid tumors (ATRT) are aggressive tumors with poor outcomes and limited treatment options, particularly in young children.…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 03, 2026 10:56 UTC
-
Tailored therapy offers new hope for tough T-Cell leukemia
Disease control Not yet recruitingTo evaluate the benefit of a precision medicine based strategy (targeted therapeutic options (TTOs)) for patients with relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) (in terms of composite remission).
Phase: PHASE2 • Sponsor: Philippe ROUSSELOT • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Engineered immune cells target stomach cancer in the belly
Disease control Not yet recruitingThe goal of this clinical research study is to study the recommended dose of TROP2 CAR/IL-15 TGFBR2 KO NK cells that can be given intraperitoneally (infused directly into the stomach area) to participants with adenocarcinoma of the stomach that has spread to the peritoneum. The s…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 03, 2026 10:56 UTC
-
Triple-Drug attack on melanoma before surgery shows promise
Disease control Not yet recruitingThis is a phase II study testing the safety and preliminary efficacy of triplet ICB in treatment naïve patients with clinical stage III or oligometastatic stage IV melanoma with resectable disease.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 03, 2026 10:43 UTC
-
New hope for CLL: drug combo aims to control disease without lifelong pills
Disease control Not yet recruitingThis is an open-label, single-arm, phase II study which will assess the safety and efficacy of BGB16673 in combination with sonrotoclax as a time-limited approach for participants with treatment-naive CLL/SLL.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:05 UTC
-
New surgical order may boost pancreatic cancer outcomes
Disease control Not yet recruiting"Pancreatic cancer, especially pancreatic ductal adenocarcinoma, is one of the most serious and deadly cancers. Its outlook is very poor, with fewer than 10% of patients surviving five years after diagnosis. This is largely because the disease is often discovered at a late stage …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Apr 24, 2026 16:07 UTC
-
Chemo-Free triplet aims to outsmart incurable lymphoma
Disease control Not yet recruitingFollicular lymphoma (FL) remains an incurable indolent B-cell lymphoma for many patients, and although rituximab-based chemoimmunotherapy can achieve high initial response rates, a substantial proportion of patients experience early progression, including POD24, which is associat…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Could a cholesterol drug boost stroke recovery? major trial underway.
Disease control Not yet recruitingThis study is a prospective, multicenter, double-blind, randomized, placebo-controlled clinical trial designed to evaluate whether early administration of PCSK9 inhibitors can effectively improve functional outcomes at 90 days in patients with ischemic stroke (AIS) associated wit…
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 01, 2026 16:01 UTC